Are generic immunosuppressants safe and effective? Clinical experience is reassuring and regulation is strict, now we need definitive evidence

B Godman, C Baumgärtel

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Increasing use of generic drugs is essential to maintain comprehensive and equitable healthcare, given current pressure on budgets through, for instance, ageing populations. Initiatives among health authorities to promote generic prescribing include educational initiatives (which in the United Kingdom has resulted in high levels of prescribing of international non-proprietary name (INN) drugs in over 80% of all prescriptions), compulsory generic substitution in pharmacies, and patients paying extra “out of pocket” expenses for a proprietary drug.[1-3] Concerns remain, however, about generic prescribing or compulsory substitution in certain drugs and drug classes, including lithium, theophyllines, some anti-epileptic drugs, and the immunosuppressants evaluated in the linked study by Molnar and colleagues (doi:10.1136/bmj.h3163).
LanguageEnglish
Article number350
JournalBMJ
DOIs
Publication statusPublished - 22 Jun 2015

Fingerprint

Immunosuppressive Agents
Pharmaceutical Preparations
Comprehensive Health Care
Drug Substitution
Generic Drugs
Pharmacies
Budgets
Theophylline
Health Expenditures
Lithium
Names
Prescriptions
Pressure
Health
Population

Keywords

  • immunosuppressants
  • pharmacy market
  • generic drugs

Cite this

@article{a8c01ffa18fe4fceabbe7c56f2d2ff24,
title = "Are generic immunosuppressants safe and effective? Clinical experience is reassuring and regulation is strict, now we need definitive evidence",
abstract = "Increasing use of generic drugs is essential to maintain comprehensive and equitable healthcare, given current pressure on budgets through, for instance, ageing populations. Initiatives among health authorities to promote generic prescribing include educational initiatives (which in the United Kingdom has resulted in high levels of prescribing of international non-proprietary name (INN) drugs in over 80{\%} of all prescriptions), compulsory generic substitution in pharmacies, and patients paying extra “out of pocket” expenses for a proprietary drug.[1-3] Concerns remain, however, about generic prescribing or compulsory substitution in certain drugs and drug classes, including lithium, theophyllines, some anti-epileptic drugs, and the immunosuppressants evaluated in the linked study by Molnar and colleagues (doi:10.1136/bmj.h3163).",
keywords = "immunosuppressants, pharmacy market, generic drugs",
author = "B Godman and C Baumg{\"a}rtel",
year = "2015",
month = "6",
day = "22",
doi = "10.1136/bmj.h3248",
language = "English",
journal = "BMJ",
issn = "0959-8138",

}

TY - JOUR

T1 - Are generic immunosuppressants safe and effective? Clinical experience is reassuring and regulation is strict, now we need definitive evidence

AU - Godman, B

AU - Baumgärtel, C

PY - 2015/6/22

Y1 - 2015/6/22

N2 - Increasing use of generic drugs is essential to maintain comprehensive and equitable healthcare, given current pressure on budgets through, for instance, ageing populations. Initiatives among health authorities to promote generic prescribing include educational initiatives (which in the United Kingdom has resulted in high levels of prescribing of international non-proprietary name (INN) drugs in over 80% of all prescriptions), compulsory generic substitution in pharmacies, and patients paying extra “out of pocket” expenses for a proprietary drug.[1-3] Concerns remain, however, about generic prescribing or compulsory substitution in certain drugs and drug classes, including lithium, theophyllines, some anti-epileptic drugs, and the immunosuppressants evaluated in the linked study by Molnar and colleagues (doi:10.1136/bmj.h3163).

AB - Increasing use of generic drugs is essential to maintain comprehensive and equitable healthcare, given current pressure on budgets through, for instance, ageing populations. Initiatives among health authorities to promote generic prescribing include educational initiatives (which in the United Kingdom has resulted in high levels of prescribing of international non-proprietary name (INN) drugs in over 80% of all prescriptions), compulsory generic substitution in pharmacies, and patients paying extra “out of pocket” expenses for a proprietary drug.[1-3] Concerns remain, however, about generic prescribing or compulsory substitution in certain drugs and drug classes, including lithium, theophyllines, some anti-epileptic drugs, and the immunosuppressants evaluated in the linked study by Molnar and colleagues (doi:10.1136/bmj.h3163).

KW - immunosuppressants

KW - pharmacy market

KW - generic drugs

UR - http://www.bmj.com/

U2 - 10.1136/bmj.h3248

DO - 10.1136/bmj.h3248

M3 - Article

JO - BMJ

T2 - BMJ

JF - BMJ

SN - 0959-8138

M1 - 350

ER -